These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The MYO9B gene is a strong risk factor for developing refractory celiac disease. Wolters VM; Verbeek WH; Zhernakova A; Onland-Moret C; Schreurs MW; Monsuur AJ; Verduijn W; Wijmenga C; Mulder CJ Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1399-405, 1405.e1-2. PubMed ID: 17967566 [TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694 [TBL] [Abstract][Full Text] [Related]
6. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease. Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205 [TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. Soderquist CR; Lewis SK; Gru AA; Vlad G; Williams ES; Hsiao S; Mansukhani MM; Park DC; Bacchi CE; Alobeid B; Green PH; Bhagat G Am J Surg Pathol; 2021 Jul; 45(7):905-916. PubMed ID: 33544565 [TBL] [Abstract][Full Text] [Related]
8. Monitoring nonresponsive patients who have celiac disease. Krauss N; Schuppan D Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways. Meng X; Carlson NR; Dong J; Zhang Y Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025 [TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. Hadithi M; Mallant M; Oudejans J; van Waesberghe JH; Mulder CJ; Comans EF J Nucl Med; 2006 Oct; 47(10):1622-7. PubMed ID: 17015897 [TBL] [Abstract][Full Text] [Related]
11. Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis. Ding L; Zhang Y; Han L; Fu L; Mei X; Wang J; Itkow J; Elabid AEI; Pang L; Yu D Oncogene; 2018 Mar; 37(10):1293-1307. PubMed ID: 29284789 [TBL] [Abstract][Full Text] [Related]
12. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line. Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798 [TBL] [Abstract][Full Text] [Related]
13. Multiple lesions of gastrointestinal tract invasion by monomorphic epitheliotropic intestinal T-cell lymphoma, accompanied by duodenal and intestinal enteropathy-like lesions and microscopic lymphocytic proctocolitis: a case series. Ishibashi H; Nimura S; Kayashima Y; Takamatsu Y; Aoyagi K; Harada N; Kadowaki M; Kamio T; Sakisaka S; Takeshita M Diagn Pathol; 2016 Jul; 11(1):66. PubMed ID: 27457239 [TBL] [Abstract][Full Text] [Related]
14. Enteropathy-Associated T cell Lymphoma. Al Somali Z; Hamadani M; Kharfan-Dabaja M; Sureda A; El Fakih R; Aljurf M Curr Hematol Malig Rep; 2021 Apr; 16(2):140-147. PubMed ID: 34009525 [TBL] [Abstract][Full Text] [Related]
15. C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells. Guo P; Nie Q; Lan J; Ge J; Qiu Y; Mao Q Biochem Biophys Res Commun; 2013 Nov; 441(1):186-90. PubMed ID: 24140063 [TBL] [Abstract][Full Text] [Related]
16. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma. Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501 [TBL] [Abstract][Full Text] [Related]